Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised, Double-blind, Placebo-controlled, Crossover Study in Healthy Adult Subjects to Investigate the Effect of Intravenous APD421, With and Without Ondansetron, on Cardiac Conduction

Trial Profile

A Randomised, Double-blind, Placebo-controlled, Crossover Study in Healthy Adult Subjects to Investigate the Effect of Intravenous APD421, With and Without Ondansetron, on Cardiac Conduction

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jan 2019

At a glance

  • Drugs Amisulpride (Primary) ; Ondansetron
  • Indications Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
  • Focus Adverse reactions
  • Sponsors Acacia Pharma
  • Most Recent Events

    • 22 Jan 2019 Results presented in an Acacia Pharma media release.
    • 22 Jan 2019 According to an Acacia Pharma media release, the company has announced the results from this study.
    • 28 Sep 2018 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top